Health M&A could increase in 2013, analysts say

10/26/2012 | Bloomberg

Health companies have large cash reserves, and drugmakers are shifting their focus from cost-cutting to filling pipelines through mergers and acquisitions, industry analysts say. Next year could top the 2,076 health deals worth $166 billion announced in the past 12 months. "What tends to drive that is the need. There's clearly a need for larger companies who are facing patent cliffs and whose own R&D machines have not panned out, to find growth," he said.

View Full Article in:

Bloomberg

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC